Key facts
- Notable investors include Booster Innovation Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Solros Tx
- ·The full record, as it builds
Funding rounds
No funding rounds for Solros Tx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Solros Tx
Developer of brain health-focused therapies designed to leverage novel mechanisms of action for treating neurological conditions. The company offers advanced treatments based on Otago University research, enabling global pharmaceutical companies to develop more effective diagnostics for patients suffering from neurological disorders.
- Sector
- Healthcare
- HQ
- Wellington, New Zealand
- Ownership
- Privately Held (backing)
Solros Tx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Solros Tx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Solros Tx in its N-PORT filings yet. We sweep new filings monthly.